NEW YORK, Sept. 17, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
US Personalized Cancer Genome Sequencing Market <\/p>\n
http:\/\/www.reportlinker.com\/p0968380\/US-Personalized-Cancer-Genome-Sequencing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics<\/a> <\/p>\n The US personalized cancer Whole-Genome Sequencing market is primarily classified into targeted genome sequencing and Whole-Genome Sequencing. Our report entitled \"US Personalized Cancer Genome Sequencing Market\" takes into account the Whole-Genome Sequencing services, i.e. one of the most attractive sectors due to its inherent capability of high revenue generation and efficiency in terms of personalized treatment. The US, which is the frontrunner in the provision of such high-end service, is on the focus by market players because of favorable demographics and rising awareness among the industry participants. <\/p>\n In order to properly analyze the virtues and significance of the US personalized cancer Whole-Genome Sequencing market, our report has effectively studied the current and future status of cancer in the whole country as well as states. In view of the fact that cancer affects some age groups in a significant manner, we have also investigated the age wise statistics of the disease. To get proper insight into the market, an in-depth analysis into the high-income group population is provided so that players can have a clear picture about their potential customer base and market to be tapped. <\/p>\n An in-depth study of the regulatory environment governing the US personalized cancer Whole-Genome Sequencing market has also been provided. It has been found that regulations related to personalized cancer sequencing are primarily governed with the accreditation of the laboratories performing the sequencing services and analysis and also the usage of FDA approved tests for conducting these tests. Further we have also discussed the various constraints faced by the industry players with suitable suggestions for overcoming them. <\/p>\n The report analyzes the competitive landscape in the market through properly analyzing the business, services and activities of the companies. It also provides the competitive benchmarking taking into account the strengths and weaknesses of each player. Overall, the report is a complete source of knowledge and statistics for the clients who want to get an in-depth understanding of the market. <\/p>\n 1. Analyst View <\/p>\n 2. Research Methodology <\/p>\n 3. Cancer Statistics by Demographics <\/p>\n<\/p>\n See more here: NEW YORK, Sept. 17, 2012 \/PRNewswire\/ -- Reportlinker.com announces that a new market research report is available in its catalogue: US Personalized Cancer Genome Sequencing Market http:\/\/www.reportlinker.com\/p0968380\/US-Personalized-Cancer-Genome-Sequencing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics<\/a> The US personalized cancer Whole-Genome Sequencing market is primarily classified into targeted genome sequencing and Whole-Genome Sequencing. Continue reading
\nUS Personalized Cancer Genome Sequencing Market<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"